Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Capanni

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis CM Capanni, E Lorefice, M C Benini, et al.
Thrombosis and Haemostasis|September 24, 1999
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levelsM Falciani, A M Gori, B Giusti, et al.
The American Journal of Cardiology|September 2, 1998
Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplastyR Abbate, R Marcucci, O Camacho-Vanegas, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Atherosclerosis|January 4, 2001
Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplastyL Chiarugi, D Prisco, E Antonucci, et al.
International Journal of Clinical & Laboratory Research|April 28, 2000
The pre-procedural platelet state predicts clinical recurrence after coronary angioplastyM Capanni, D Prisco, E Antonucci, et al.
Minerva Cardioangiologica|February 12, 2000
[Changes in fibrinolysis after primary PTCA]E Antonucci, S Fedi, M Falai, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Autoimmunity|August 6, 1999
High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart diseaseA Farsi, M P Domeneghetti, S Fedi, et al.
Minerva Cardioangiologica|February 12, 2000
[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs]A Rogolino, A Farsi, T Brunelli, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis CM Capanni, E Lorefice, M C Benini, et al.
Thrombosis and Haemostasis|September 24, 1999
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levelsM Falciani, A M Gori, B Giusti, et al.
The American Journal of Cardiology|September 2, 1998
Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplastyR Abbate, R Marcucci, O Camacho-Vanegas, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Atherosclerosis|January 4, 2001
Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplastyL Chiarugi, D Prisco, E Antonucci, et al.
International Journal of Clinical & Laboratory Research|April 28, 2000
The pre-procedural platelet state predicts clinical recurrence after coronary angioplastyM Capanni, D Prisco, E Antonucci, et al.
Minerva Cardioangiologica|February 12, 2000
[Changes in fibrinolysis after primary PTCA]E Antonucci, S Fedi, M Falai, et al.
Blood|April 6, 2001
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI Volpi, K Perruccio, A Tosti, et al.
Autoimmunity|August 6, 1999
High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart diseaseA Farsi, M P Domeneghetti, S Fedi, et al.
Minerva Cardioangiologica|February 12, 2000
[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs]A Rogolino, A Farsi, T Brunelli, et al.
Pageof 3